|
1
|
Nasu Y, Saika T, Ebara S, Kusaka N, Kaku
H, Abarzua F, Manabe D, Thompson TC and Kumon H: Suicide gene
therapy with adenoviral delivery of HSV-tK gene for patients with
local recurrence of prostate cancer after hormonal therapy. Mol
Ther. 15:834–840. 2007.PubMed/NCBI
|
|
2
|
Fukazawa T, Matsuoka J, Yamatsuji T, Maeda
Y, Durbin ML and Naomoto Y: Adenovirus-mediated cancer gene therapy
and virotherapy (Review). Int J Mol Med. 25:3–10. 2010.PubMed/NCBI
|
|
3
|
Niwa H, Yamamura K and Miyazaki J:
Efficient selection for high-expression transfectants with a novel
eukaryotic vector. Gene. 108:193–199. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Araki K, Araki M, Miyazaki J and Vassalli
P: Site-specific recombination of a transgene in fertilized eggs by
transient expression of Cre recombinase. Proc Natl Acad Sci USA.
92:160–164. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ebara S, Shimura S, Nasu Y, Kaku H, Kumon
H, Yang G, Wang J, Timme TL, Aguilar-Cordova E and Thompson TC:
Gene therapy for prostate cancer: toxicological profile of four
HSV-tk transducing adenoviral vectors regulated by different
promoters. Prostate Cancer Prostatic Dis. 5:316–325. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Watanabe M, Nasu Y, Kashiwakura Y, Kusumi
N, Tamayose K, Nagai A, Sasano T, Shimada T, Daida H and Kumon H:
Adeno-associated virus 2-mediated intratumoral prostate cancer gene
therapy: long-term maspin expression efficiently suppresses tumor
growth. Hum Gene Ther. 16:699–710. 2005. View Article : Google Scholar
|
|
7
|
Xu ZL, Mizuguchi H, Ishii-Watabe A, Uchida
E, Mayumi T and Hayakawa T: Optimization of transcriptional
regulatory elements for constructing plasmid vectors. Gene.
272:149–156. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu ZL, Mizuguchi H, Ishii-Watabe A, Uchida
E, Mayumi T and Hayakawa T: Strength evaluation of transcriptional
regulatory elements for transgene expression by adenovirus vector.
J Control Release. 81:155–163. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Young JL, Benoit JN and Dean DA: Effect of
a DNA nuclear targeting sequence on gene transfer and expression of
plasmids in the intact vasculature. Gene Ther. 10:1465–1470. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song JS: Enhanced expression of apoptin by
the Myc-Max binding motif and SV40 enhancer for SCLC gene therapy.
Biosci Biotechnol Biochem. 69:51–55. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim SJ, Lee HS, Shin JH, Kim CG, Jeong S,
Park K, Choe H and Lee H: Preferentially enhanced gene expression
from a synthetic human telomerase reverse transcriptase promoter in
human cancer cells. Oncol Rep. 16:975–979. 2006.PubMed/NCBI
|
|
12
|
Kojima T, Hashimoto Y, Watanabe Y, Kagawa
S, Uno F, Kuroda S, Tazawa H, Kyo S, Mizuguchi H, Urata Y, Tanaka N
and Fujiwara T: A simple biological imaging system for detecting
viable human circulating tumor cells. J Clin Invest. 119:3172–3181.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Watanabe M, Ueki H, Ochiai K, Huang P,
Kobayashi Y, Nasu Y, Sasaki K, Kaku H, Kashiwakura Y and Kumon H:
Advanced two-step transcriptional amplification as a novel method
for cancer-specific gene expression and imaging. Oncol Rep.
26:769–775. 2011.PubMed/NCBI
|
|
14
|
Ueki H, Watanabe M, Kaku H, Huang P, Li
SA, Ochiai K, Hirata T, Noguchi H, Yamada H, Takei K, Nasu Y,
Kashiwakura Y and Kumon H: A novel gene expression system for
detecting viable bladder cancer cells. Int J Oncol. 41:135–140.
2012.PubMed/NCBI
|
|
15
|
Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y
and Namba M: A REIC gene shows down-regulation in human
immortalized cells and human tumor-derived cell lines. Biochem
Biophys Res Commun. 268:20–24. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Abarzua F, Sakaguchi M, Takaishi M, Nasu
Y, Kurose K, Ebara S, Miyazaki M, Namba M, Kumon H and Huh NH:
Adenovirus-mediated overexpression of REIC/Dkk-3 selectively
induces apoptosis in human prostate cancer cells through activation
of c-Jun-NH2-kinase. Cancer Res. 65:9617–9622. 2005. View Article : Google Scholar
|
|
17
|
Kashiwakura Y, Ochiai K, Watanabe M,
Abarzua F, Sakaguchi M, Takaoka M, Tanimoto R, Nasu Y, Huh NH and
Kumon H: Down-regulation of inhibition of differentiation-1 via
activation of activating transcription factor 3 and Smad regulates
REIC/Dickkopf-3-induced apoptosis. Cancer Res. 68:8333–8341. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kawasaki K, Watanabe M, Sakaguchi M,
Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH,
Kumon H and Date H: REIC/Dkk-3 overexpression downregulates
P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces
apoptosis in breast cancer. Cancer Gene Ther. 16:65–72. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Watanabe M, Kashiwakura Y, Huang P, Ochiai
K, Futami J, Li SA, Takaoka M, Nasu Y, Sakaguchi M, Huh NH and
Kumon H: Immunological aspects of REIC/Dkk-3 in monocyte
differentiation and tumor regression. Int J Oncol. 34:657–663.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sakaguchi M, Kataoka K, Abarzua F,
Tanimoto R, Watanabe M, Murata H, Than SS, Kurose K, Kashiwakura Y,
Ochiai K, Nasu Y, Kumon H and Huh NH: Overexpression of REIC/Dkk-3
in normal fibroblasts suppresses tumor growth via induction of
interleukin-7. J Biol Chem. 284:14236–14244. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang K, Watanabe M, Kashiwakura Y, Li SA,
Edamura K, Huang P, Yamaguchi K, Nasu Y, Kobayashi Y, Sakaguchi M,
Ochiai K, Yamada H, Takei K, Ueki H, Huh NH, Li M, Kaku H, Na Y and
Kumon H: Expression pattern of REIC/Dkk-3 in various cell types and
the implications of the soluble form in prostatic acinar
development. Int J Oncol. 37:1495–1501. 2010.PubMed/NCBI
|
|
22
|
Ochiai K, Watanabe M, Ueki H, Huang P,
Fujii Y, Nasu Y, Noguchi H, Hirata T, Sakaguchi M, Huh NH,
Kashiwakura Y, Kaku H and Kumon H: Tumor suppressor REIC/Dkk-3
interacts with the dynein light chain, Tctex-1. Biochem Biophys Res
Commun. 412:391–395. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hirata T, Watanabe M, Kaku H, Kobayashi Y,
Yamada H, Sakaguchi M, Takei K, Huh NH, Nasu Y and Kumon H:
REIC/Dkk-3-encoding adenoviral vector as a potentially effective
therapeutic agent for bladder cancer. Int J Oncol. 41:559–564.
2012.PubMed/NCBI
|
|
24
|
Wang CY, Guo HY, Lim TM, Ng YK, Neo HP,
Hwang PY, Yee WC and Wang S: Improved neuronal transgene expression
from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
J Gene Med. 7:945–955. 2005. View
Article : Google Scholar : PubMed/NCBI
|
